Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000146

EVP, Finance & CFO sold 225,220 shares at an average $72.43 ($16,313,676)

  • EVP, Finance & CFO acquired 174,999 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

HOUGEN ELIZABETH L · EVP, Finance & CFO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-16 Exercise or conversion : show line 1 in the form 10b5-1 +60,299 $60.89 $3,671,606 193,180 D
2026-03-16 Exercise or conversion : show line 2 in the form 10b5-1 +61,041 $56.78 $3,465,908 254,221 D
2026-03-16 Exercise or conversion : show line 3 in the form 10b5-1 +33,118 $32.60 $1,079,647 287,339 D
2026-03-16 Exercise or conversion : show line 4 in the form 10b5-1 +20,541 $37.58 $771,931 307,880 D
2026-03-16 Sale : show line 5 in the form 10b5-1 −205,608 $72.38 $14,882,113 102,272 D
2026-03-16 Sale : show line 6 in the form 10b5-1 −9,440 $72.77 $686,902 92,832 D
2026-03-17 Sale : show line 7 in the form 10b5-1 −10,172 $73.21 $744,662 82,660 D
Open-market sales · 225,220 sh · avg $72.43 · $16,313,676

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2026-03-16 Exercise or conversion : show line 8 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −33,118 0 D
2026-03-16 Exercise or conversion : show line 9 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −20,541 5,405 D
2026-03-16 Exercise or conversion : show line 10 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −61,041 0 D
2026-03-16 Exercise or conversion : show line 11 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −60,299 0 D
Loading xslF345X06/edgardoc.xml…